HGH is a FDA-approved drug. In August 1996, the FDA approved HGH for use by adult patients. Prior to this, it was authorized only for use to promote growth in HGH-deficient children. The new indication is somatotropin (growth hormone) deficiency syndrome (SDS), resulting from pituitary disease, hypothalamic disease, surgery, radiation therapy, or injury.

In effect, the FDA approval covers the use of HGH for anti-aging purposes since low levels of HGH or IGF-1 indicate a failure of the pituitary to release adequate amounts of this vital substance.

In addition, the signs of SDS, such as decreased physical mobility, lower energy, and higher risk of cardiovascular disease, are exactly the same as those seen in aging adults with low HGH levels.

The FDA approval for HGH in adults means that any doctor or physician may now prescribe it to their HGH-deficient aging patients without any concern of practicing outside of conventional orthodox mainstream medicine.

If you are concerned about your on-line human growth hormone provider we recommend using the HGHNews.US “Reputable Point of Purchase” program which identifies and highlights safe and reputable on-line points of purchase. Additionally, we recommend using our free FDA Warning Letter Tracking Service, this services offers a convenient and updated listing of warning letters sent out regarding human growth hormone (HGH).